Company Filing History:
Years Active: 2007
Title: The Innovative Contributions of Daniel Denton
Introduction
Daniel Denton is a notable inventor based in Irving, TX, who has made significant contributions to the field of antimicrobial research. His work focuses on developing compounds that combat drug-resistant microorganisms, which is a pressing issue in modern medicine.
Latest Patents
Denton holds a patent for C-25 carbamate rifamycin derivatives with activity against drug-resistant microbes. This patent describes compounds that relate to rifamycin derivatives exhibiting antimicrobial activities, particularly against drug-resistant microorganisms. The compounds are designed to have another functional group or pharmacophore covalently attached through a carbamate linkage. This innovative approach allows the resulting compounds to exert their antimicrobial activity through a dual-function mechanism, thereby reducing the frequency of resistance.
Career Highlights
Denton is currently associated with Cumbre Pharmaceuticals Inc., where he continues to advance his research in antimicrobial compounds. His dedication to innovation in this field has positioned him as a key figure in the fight against drug-resistant infections.
Collaborations
Denton collaborates with various professionals in his field, including his coworker Susan Harran, to enhance the development of effective antimicrobial solutions.
Conclusion
Daniel Denton's work exemplifies the importance of innovation in addressing critical health challenges. His contributions to antimicrobial research are vital in the ongoing battle against drug-resistant microbes.